Table 3

Baseline characteristics of patients with moyamoya disease according to prehospital antiplatelet use in propensity-matched patients (n=578)

CharacteristicsNo antiplatelet use (n=289)Antiplatelet use (n=289)p Value
Male, number (%)103 (35.6)93 (32.2)0.380
Age, mean (SD), years31.3 (18.9)30.9 (18.8)0.796
Body mass index, mean (SD)22.1 (5.7)22.0 (4.5)0.780
Smoking history, number (%)66 (22.8)52 (18.0)0.149
Medical history, number (%)
 Hypertension36 (12.5)49 (17.0)0.127
 Diabetes mellitus13 (4.5)17 (5.9)0.453
 Hyperlipidaemia28 (9.7)26 (9.0)0.775
Emergency hospitalisation, number (%)27 (9.3)25 (8.7)0.771
Day of the week of hospital admission, number (%)
 Sunday13 (4.5)8 (2.8)0.336
 Monday75 (26.0)73 (25.3)
 Tuesday59 (20.4)62 (21.5)
 Wednesday62 (21.5)59 (20.4)
 Thursday30 (10.4)47 (16.3)
 Friday42 (14.5)31 (10.7)
 Saturday8 (2.8)9 (3.1)
Number of days from stroke onset, number (%)
 0–321 (7.3)24 (8.3)0.209
 4–74 (1.4)0 (0.0)
 ≥8159 (55.0)153 (52.9)
 Asymptomatic or not available105 (36.3)112 (38.8)
Japan Coma Scale on hospital admission, number (%)
 0278 (96.2)273 (94.5)0.261
 1–39 (3.1)16 (5.5)
 10–301 (0.4)0 (0.0)
 100–3001 (0.4)0 (0.0)
Charlson Comorbidity Index score on hospital admission, number (%)
 1167 (57.8)168 (58.1)0.522
 263 (21.8)54 (18.7)
 327 (9.3)34 (11.8)
 421 (7.3)18 (6.2)
 57 (2.4)13 (4.5)
 64 (1.4)2 (0.7)
 70 (0.0)0 (0.0)
CSC score, mean (SD)18.0 (2.8)18.1 (3.5)0.944
Modified Rankin Scale score on hospital admission, number (%)
 0142 (49.1)148 (51.2)0.261
 1105 (36.3)114 (39.5)
 232 (11.1)19 (6.6)
 34 (1.4)6 (2.1)
 45 (1.7)2 (0.7)
 51 (0.4)0 (0.0)
  • CSC, Comprehensive Stroke Centre.